SOFIE

We are dedicated to improving patient outcomes by developing, supplying and delivering molecular diagnostics and therapeutics (theranostics).

[SOFIE @sofiebio]

@grimmrad #facts

[ImaginAbInc @ImaginAbInc]

In January, we launched our iPREDICT clinical trial globally in the US, Australia, and Europe. ​

We are proud to announce the first patient dosed in Australia.​

​Read more here: https://t.co/FZd5E6vmHG

#Australiabiotech #immunotherapy #immunooncology #clinicaltrials

[SOFIE @sofiebio]

https://t.co/9g2j3NvBI2

[Diane M. Simeone, MD @MadameSurgeon]

Very excited to test the ability of a novel molecular imaging agent targeting fibroblast activated protein (FAP) to pick up pancreatic cancer!” @sofie @elcinzan @nyulangone ⁦@Perlmutter_CC⁩ #imagingpancreaticcancer https://t.co/VzUyIXjvmL

[FSMN @faststocknewss]

Eisai Co. and partner Biogen Inc. said their Alzheimer’s drug lecanemab slowed the disease, becoming the first medicine to clearly blunt the progression of the most common type of dementia in a final-phase trial $BIIB

[JNM @JournalofNucMed]

Read the FDA's reasoning and remember that @NCCN and @SNM_MI guidelines support the use of other validated and FDA-approved imaging probes for PLUVICTO treatment stratification. https://t.co/t8dzkUHfmr

#PrecisionMedicine #NucMed #ProstateCancer

[WMIS WMIC @WMISWMIC]

This is your last week to submit an abstract for WMIC! Submit by July 15th, 2022.
Present your science in Miami and don't forget to book your hotel:
https://t.co/qSrMSfp7ny

[Clinical Nuclear Medicine @ClinNuclearMed]

Current Issue: Fibrous Dysplasia Mimicking Skeletal Metastasis on 68Ga-FAPI PET Imaging https://t.co/LWPJbAmUjF

[SOFIE @sofiebio]

FAP session at Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting attracts packed audience https://t.co/1rhPqLiwyn

[Sara Harsini @sara_harsini]

Thanks @SNM_MI for the 2022 Alavi-Mandell award for this @JournalofNucMed publication. Recognition goes to all authors. #PSMA #ProstateCancer #nuclearmedicine https://t.co/Y3VqufkvIW

[SOFIE @sofiebio]

How perfect. Dr Gambhir would be proud.

[SNMMI @SNM_MI]

Andrei Iagaru, MD, FACNM, has been named as the first recipient of the SNMMI Sam Gambhir Trailblazer Award. Congratulations on this honor! #SNMMI22 #NuclearMedicine

[Tom @petctimaging]

Impact of 18F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer https://t.co/Ixp3gbhBYZ

[JNM @JournalofNucMed]

O. Sartor discusses the role of PSMA PET/CT for selecting patients for radioligand therapy. Thoughts? Please comment! https://t.co/q0tk80thVU

#MedicalImaging #PETCT #ProstateCancer @sartor_oliver

[Michael Hofman @DrMHofman]

Predictors and Real-World Use of Prostate-Specific Radioligand Therapy: PSMA and Beyond
@asco Education Book #ASCO22
https://t.co/uNpNRavOQl
@DrAGafita @LouiseKostos @CalaisJeremie @pros_tic

[WMIS WIMIN @WIMIN_WMIS]

We invite all WMIC 2022 attendees to fill out our pre-conference survey!

✨We want your input and feedback on WIMIN events you'd like to see at the upcoming WMIC conference. Fill out a survey & have a chance to win a $25 Amazon gift cards✨

https://t.co/QsIbghDzaU

@WMISWMIC

[David Lewis @DavidYLewis]

Impressive and inspiring talk by Jason Lewis @LewisLabMSKCC at the @CRUK_BI today. Jason gave us an excellent vision of the future for #PET imaging and #theranostics. Phenomenal data.

[Thomas Hope @thomashopemd]

Also great to see 177Lu-PSMA-617 added to the NCCN guidelines. As expected post-chemo and post-ARTT. Nice speedy updates by the NCCN panel. #PSMARLT https://t.co/FbkXOwhClR

[Thomas Hope @thomashopemd]

Glad to see that the NCCN agrees that either 18F-DCFPyL or 68Ga-PSMA-11 should be used for selection of patients for 177Lu-PSMA-617 radioligand therapy. Hopefully we can put this issue to rest as soon as possible! #PSMAPET - https://t.co/FbkXOwhClR

[SOFIE @sofiebio]

Our goal

[Harvard Business Review @HarvardBiz]

To attract and retain the best people, we must redesign jobs around a simple but powerful concept: love for the content of the work itself. https://t.co/ustOvh85LJ

[Julie Sutcliffe @juliesut8]

Look forward to seeing you all @WMISWMIC #molecular imaging #science #innovation @UCDavisResearch @LewisLabMSKCC @UCDavisCMGI @juliesut8